Understanding LRRK2 S90/S935 Phosphorylation in important for therapeutic LRRK2 inhibitor Development

Funding of this project reflects Shake It Up and MJFFs ongoing commitment to the talent of the team at NeuRA and their ability to answer some of the key questions surrounding LRRK2 research.

From a Shake It Up perspective we are absolutely delighted that this world leading research exists here in Australia.

Having recently committed such large sums of money to new projects, Shake It Up must now generate additional revenue if we are to maintain our commitment.

To that end we are seeking to raise an additional $1M by the end of 2016 and we need your help.

Please contribute today so that we can maintain our pace in the quest for a cure.

About Nic Dzmako
Dr Nic DzamkoNic Dzamko works with Professor Glenda Halliday to understand the causes of Parkinson’s disease. In Particular Nic focuses on the leucine-rich repeat kinase 2 (LRRK2), the leading genetic cause of autosomal dominant Parkinson’s disease. Nic has a biomedical science degree with first class honours and a Chancellors letter of commendation from Flinders University of South Australia and a PhD from the University of Melbourne. Nic has trained at the Garvan Institute of Medical Research and at the MRC Protein Phosphorylation Unit in Dundee, Scotland.

SHARE THIS ARTICLE

SIGN UP FOR EMAIL UPDATES

GET PARKINSON'S RESEARCH NEWS, FOUNDATION UPDATES, INVITATIONS TO EVENTS AND MORE.